|
|
|
Volumn 58, Issue 1, 1996, Pages
|
|
Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
CIDOFOVIR;
CYTOSINE;
DNA DIRECTED DNA POLYMERASE;
DRUG DERIVATIVE;
ORGANOPHOSPHORUS COMPOUND;
PHOSPHONIC ACID DERIVATIVE;
ANIMAL;
ANIMAL DISEASE;
ARTICLE;
CATTLE;
CLINICAL TRIAL;
DNA VIRUS;
DRUG EFFECT;
GENETICS;
HALF LIFE TIME;
HUMAN;
METABOLISM;
MOLECULAR GENETICS;
NUCLEOTIDE SEQUENCE;
POINT MUTATION;
VIRUS INFECTION;
VIRUS REPLICATION;
ANIMALS;
ANTIVIRAL AGENTS;
BASE SEQUENCE;
CATTLE;
CLINICAL TRIALS;
CYTOSINE;
DNA VIRUSES;
DNA-DIRECTED DNA POLYMERASE;
HALF-LIFE;
HUMANS;
MOLECULAR SEQUENCE DATA;
ORGANOPHOSPHORUS COMPOUNDS;
PHOSPHONIC ACIDS;
POINT MUTATION;
VIRUS DISEASES;
VIRUS REPLICATION;
|
|
EID: 0029704912
PISSN: 03026469
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (102)
|
|
References (0)
|
